Discover our patented animal soft chew manufacturing technology — a proprietary low-temperature extrusion process that produces water-free, treat-like oral therapeutics with superior palatability, consistent quality, and broad API compatibility across any companion animal species.Since 2006, we've been the sole global CRO/CDMO dedicated to animal health. We're proud to support companies big and small with unparalleled, comprehensive support right across the animal health product development cycle from 'molecule to market'.
Soft chew extrusion is a continuous manufacturing process where API and excipients are metered into a twin-screw extruder, blended under controlled conditions, and formed into a consistent chewable matrix. Unlike standard compression methods, our continuous extrusion process ensures even API distribution at low drug loads, supports dissolved or solid API, and minimises batch-to-batch variability.Animal health is far more than an industry; it’s our purpose. From beloved companion animals to farm animals, we believe that when their lives are made better, we're all the better for it.
Our process uses a uniquely gentle, low-temperature approach to protect heat-sensitive APIs and minimise free water content, ensuring a stable, high-quality soft chew.
Dose strength is adjustable simply by changing the cut length of the extruded matrix.
Extrusion enables lipid components and flavour carriers to be incorporated at higher loads than compression-based alternatives, making taste-masking more effective and texture more treat-like. The result is better acceptance, easier at-home administration, and improved compliance across companion animal species.
Extrusion supports both immediate- and sustained-release formulations through excipient selection. Unlike standard tablets, dissolved API can also be incorporated into the matrix to enhance bioavailability relative to the crystalline form, ensuring your therapy delivers the optimal therapeutic impact.
